BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19467767)

  • 1. Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
    Judlin P; Thiebaugeorges O
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):177-9. PubMed ID: 19467767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.
    Ross JD; Cronjé HS; Paszkowski T; Rakoczi I; Vildaite D; Kureishi A; Alefelder M; Arvis P; Reimnitz P;
    Sex Transm Infect; 2006 Dec; 82(6):446-51. PubMed ID: 16723364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
    Haggerty CL; Ness RB
    Clin Infect Dis; 2007 Apr; 44(7):953-60. PubMed ID: 17342647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in managing pelvic inflammatory disease.
    Judlin P
    Curr Opin Infect Dis; 2010 Feb; 23(1):83-7. PubMed ID: 19935421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial.
    Aşicioğlu O; Gungorduk K; Ozdemir A; Ertas IE; Yildirim G; Sanci M; Ark C
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):116-21. PubMed ID: 23993130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
    Trent M; Chung SE; Forrest L; Ellen JM
    Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.
    Judlin P; Liao Q; Liu Z; Reimnitz P; Hampel B; Arvis P
    BJOG; 2010 Nov; 117(12):1475-84. PubMed ID: 20716255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations and rationale for the treatment of pelvic inflammatory disease.
    Jaiyeoba O; Lazenby G; Soper DE
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):61-70. PubMed ID: 21171878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease.
    Boothby M; Page J; Pryor R; Ross JD
    Int J STD AIDS; 2010 Mar; 21(3):195-7. PubMed ID: 20215625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic therapy in the treatment of inflammatory diseases in the minor pelvis].
    Vasiljević M; Marković A; Ganović R; Jovanović R
    Srp Arh Celok Lek; 1996; 124(7-8):193-6. PubMed ID: 9102846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
    Heinonen PK; Teisala K; Miettinen A; Aine R; Punnonen R; Grönroos P
    Scand J Infect Dis Suppl; 1989; 60():66-73. PubMed ID: 2756353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pelvic inflammatory disease.
    Cunha BA
    Clin Pharm; 1990 Apr; 9(4):275-85. PubMed ID: 2184973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiologic basis of diagnosis and treatment of pelvic inflammatory disease].
    Quentin R; Verdon R
    J Gynecol Obstet Biol Reprod (Paris); 2012 Dec; 41(8):850-63. PubMed ID: 23140621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.
    Mikamo H; Iwasaku K; Yamagishi Y; Matsumizu M; Nagashima M
    J Infect Chemother; 2014 Jul; 20(7):429-35. PubMed ID: 24787738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in gonorrhea and pelvic inflammatory disease.
    Handsfield HH
    J Med; 1983; 14(4):281-305. PubMed ID: 6423757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of uncomplicated pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines].
    Verdon R
    Gynecol Obstet Fertil Senol; 2019 May; 47(5):418-430. PubMed ID: 30878689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new therapeutic strategy using a ofloxacin-amoxicillin-clavulanic acid combination in the treatment of upper gynecologic infections. Apropos of 123 cases].
    Verhoest P; Fernandez H; Henry-Suchet J; Orfila J; Boulanger JC
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(1):39-46. PubMed ID: 8157889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
    Heinonen PK; Leinonen M
    Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of common STDs: Part II. Vaginal infections, pelvic inflammatory disease and genital warts.
    Woodward C; Fisher MA
    Am Fam Physician; 1999 Oct; 60(6):1716-22. PubMed ID: 10537386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of sexually transmitted diseases.
    Med Lett Drugs Ther; 1986 Feb; 28(708):23-8. PubMed ID: 3754031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.